Skip to main content
placeholder image

PET and PK analysis of the humanized monoclonal anti-VEGF antibody HuMV833. An EORTC-biological treatment development group phase I study

Journal Article


Abstract


Publication Date


  • 2001

Citation


  • Jayson, G. C., Zweit, J., Mulatero, C., Hastings, D., Julyan, P., Ranson, M., . . . Zweirzina, H. (2001). PET and PK analysis of the humanized monoclonal anti-VEGF antibody HuMV833. An EORTC-biological treatment development group phase I study. European Journal of Cancer, 37, s101. doi:10.1016/s0959-8049(01)80467-6

Web Of Science Accession Number


Start Page


  • s101

Volume


  • 37

Abstract


Publication Date


  • 2001

Citation


  • Jayson, G. C., Zweit, J., Mulatero, C., Hastings, D., Julyan, P., Ranson, M., . . . Zweirzina, H. (2001). PET and PK analysis of the humanized monoclonal anti-VEGF antibody HuMV833. An EORTC-biological treatment development group phase I study. European Journal of Cancer, 37, s101. doi:10.1016/s0959-8049(01)80467-6

Web Of Science Accession Number


Start Page


  • s101

Volume


  • 37